Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2017
HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2Ariella B Hanker, Joan T Garrett, Mónica Valeria Estrada, et al.Nature Communications|March 14, 2024
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancerChang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, et al.Cancer Research Communications|July 28, 2023
Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor-positive Breast Cancers for Targeted TreatmentBeom-Jun Kim, Ze-Yi Zheng, Jonathan T Lei, et al.Elife|November 12, 2020
A versatile oblique plane microscope for large-scale and high-resolution imaging of subcellular dynamicsEtai Sapoznik, Bo-Jui Chang, Jaewon Huh, et al.Cancer Immunology Research|May 13, 2022
Epigenetic Repression of STING by MYC Promotes Immune Evasion and Resistance to Immune Checkpoint Inhibitors in Triple-Negative Breast CancerKyung-Min Lee, Chang-Ching Lin, Alberto Servetto, et al.Ebiomedicine|June 27, 2025
A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancerMaxwell R Lloyd, Rosario Chica-Parrado, Caroline M Weipert, et al.Cancer Discovery|April 9, 2024
ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate CancerYaru Xu, Yuqiu Yang, Zhaoning Wang, et al.Molecular & Cellular Proteomics : MCP|May 9, 2015
Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast CancerChristian D Young, Lisa J Zimmerman, Daisuke Hoshino, et al.The Journal of Clinical Investigation|December 9, 2025
CD8+ T cells in the tumor microenvironment modulate response to endocrine therapy in breast cancerFabiana Napolitano, Yunguan Wang, Dhivya R Sudhan, et al.Nature Communications|March 28, 2019
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancerLuigi Formisano, Yao Lu, Alberto Servetto, et al.Pageof 4